NCT03723980

Brief Summary

This study evaluates the role of propolis paste as compared to calcium hydroxide (when used as intracanal medication) in prevention and treatment of pain after root canal treatment in necrotic (infected) teeth. Half of the participants will receive calcium hydroxide, while the other half will receive propolis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2017

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 16, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2018

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 23, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 30, 2018

Completed
7 months until next milestone

Results Posted

Study results publicly available

June 6, 2019

Completed
Last Updated

June 6, 2019

Status Verified

March 1, 2019

Enrollment Period

5 months

First QC Date

October 23, 2018

Results QC Date

November 4, 2018

Last Update Submit

March 3, 2019

Conditions

Keywords

Flare up

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity Measure: Visual Analogue Pain Scale

    Self recorded pain intensity by the patients at 4 hours, 12 hours, day 2, day 3 and day 4 after root canal preparation and intracanal medicament insertion (first visit). Pain intensity recorded on a Visual Analogue Scale from 0 to 100. Patients who experience no or mild pain; and do not require analgesic will record their pain intensity from 0 to 24. Patients who experience moderate pain; and require Over-the-counter analgesic will record pain intensity from 25 to 49. Patients who experience severe pain; and require use of codeine containing medicine will record their pain intensity from 50 to 74. Patients who experience extreme pain, and no medicine is able to relieve their pain will record pain intensity from 75 to 100. lower pain score (intensity) is a better outcome as compared to higher pain intensity (score)

    4 hours, 12 hours, day 2, day 3 and day 4

Secondary Outcomes (2)

  • Acute Increase in Pain Score (Acute Exacerbation of Pain)

    4 hours, 12 hours, day 2, day 3, and day 4

  • Difference of Pain Score Between Different Time Intervals

    4 hours, 12 hours, day 2, day 3, and day 4

Other Outcomes (2)

  • Difference of Pain Scores Between Males and Females

    4 hours, 12 hours, day 2, day 3, and day 4

  • Difference of Pain Scores Between Different Age Groups

    4 hours, 12 hours, day 2, day 3, and day 4

Study Arms (2)

Control Group or Group I or Calcium hydroxide Group

ACTIVE COMPARATOR
Drug: Calcium Hydroxide

Experimental Group or Group II or Propolis Group

EXPERIMENTAL
Drug: Propolis

Interventions

it is a natural product obtained from beehive. it has been evaluated for biocompatibility and toxicity; and it is found that it is extremely biocompatible material. In our study, propolis powder will be mixed with saline in a ratio of 1 : 1.5 (propolis powder(wt) / saline(vol)) to form paste; and inserted into the root canals. it will be inserted once and will remain in root canals for 4 days.

Also known as: Bee glue
Experimental Group or Group II or Propolis Group

it is a synthetic antimicrobial intracanal medicament and gold standard to which other medicaments are being compared. approximately 150 mg of calcium hydroxide paste will be inserted in the root canal. it will be inserted only once and will remain in root canals for 4 days.

Control Group or Group I or Calcium hydroxide Group

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Single rooted Necrotic teeth with symptomatic or asymptomatic periapical periodontitis having periapical widening or radiolucency without bone expansion (PAI index 2, 3 and 4).
  • Teeth with favorable root morphology.
  • Teeth with closed apex.

You may not qualify if:

  • Teeth with PAI index 1 and 5.
  • Patients who are on antibiotics.
  • Patient with recent trauma to the jaw.
  • Teeth with open apex
  • Multi-rooted teeth.
  • Vital teeth.
  • Non-restorable teeth.
  • Unfavorable root morphology (severely curved, dilacerated, severely sclerosed or obliterated).
  • Teeth associated with soft tissue abscess or swelling.
  • Teeth with external or internal root resorption
  • Re-treatment cases.
  • Periodontally compromised teeth (like mobile teeth and teeth with excessive bone loss).
  • Teeth requiring endodontic surgery.
  • Teeth requiring non-surgical endodontic treatment of multiple teeth in the same or opposing quadrant.
  • Medically compromised patients (ASA-III and above), patients with special communication needs or who doesn't understand Urdu or English language.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dow International Dental College

Karachi, Sindh, 75500, Pakistan

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

PropolisCalcium Hydroxide

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Resins, PlantBiopolymersPolymersMacromolecular SubstancesPlant ExudatesBiological ProductsComplex MixturesHydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytes

Results Point of Contact

Title
Dr. Juzer Shabbir Saifee
Organization
Dow University of Health Sciences

Study Officials

  • Juzer S Saifee

    Dow University of Health Sciences

    PRINCIPAL INVESTIGATOR
  • Fazal R Qazi

    Dow University of Health Sciences

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 23, 2018

First Posted

October 30, 2018

Study Start

November 16, 2017

Primary Completion

April 24, 2018

Study Completion

October 15, 2018

Last Updated

June 6, 2019

Results First Posted

June 6, 2019

Record last verified: 2019-03

Locations